Primary Site >> Biliary tract Cancer

Gene >> CTF1

Journal: Oncologist. 2012;17(12):1504-7.
Title: Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
Author: Zhu, Andrew X|Knox, Jennifer J
PMID: 23220842
Journal: Eur J Cancer. 2013 Jan;49(2):329-35.
Title: Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study.
Author: Walter, Thomas|Horgan, Anne M|McNamara, Mairead|McKeever, Liz|Min, Trisha|Hedley, David|Serra, Stefano|Krzyzanowska, Monika K|Chen, Eric|Mackay, Helen|Feld, Ronald|Moore, Malcolm|Knox, Jennifer J
PMID: 22947649
Journal: Chemotherapy. 2014;60(2):91-8.
Title: Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer.
Author: Kang, Eun Joo|Choi, Yoon Ji|Kim, Jung Sun|Park, Kyong Hwa|Oh, Sang Chul|Seo, Jae Hong|Kim, Hong Jun|Kang, Ka-won|Yu, Eun Sang|Shin, Sang W|Kim, Yeul H|Kim, Jun Suk
PMID: 25720697
Journal: Cancer. 2015 Sep 15;121(18):3290-7.
Title: Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Enterologues Oncologues.
Author: Brieau, Bertrand|Dahan, Laetitia|De Rycke, Yann|Boussaha, Tarek|Vasseur, Philippe|Tougeron, David|Lecomte, Thierry|Coriat, Romain|Bachet, Jean-Baptiste|Claudez, Pierre|Zaanan, Aziz|Soibinet, Pauline|Desrame, Jerome|Thirot-Bidault, Anne|Trouilloud, Isabell
PMID: 26052689